Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to providing the pharmaceutical industry with cutting-edge compounds that redefine treatment paradigms. Tegoprazan (CAS 942195-55-3) is a prime example of this, emerging as a significant player in the field of acid-related gastrointestinal disorder management due to its innovative mechanism as a potassium-competitive acid blocker (P-CAB).
The core strength of Tegoprazan lies in its direct, reversible inhibition of the gastric H+/K+-ATPase. This targeted Tegoprazan mechanism of action results in rapid and potent acid suppression, offering a distinct advantage over traditional proton pump inhibitors (PPIs). Its effectiveness is particularly noted in managing conditions such as GERD and peptic ulcers, where sustained acid control is paramount. The proven efficacy in Tegoprazan for GERD treatment and peptic ulcer management underscores its importance.
When comparing Tegoprazan vs PPI efficacy, studies consistently highlight Tegoprazan's ability to achieve higher intragastric pH levels and maintain them for longer durations. This enhanced acid blockade is beneficial not only for symptom relief but also for supporting other therapeutic interventions. For instance, research indicates Tegoprazan’s potential role in improving the efficacy of antibiotic regimens for Helicobacter pylori eradication. This application showcases the broad therapeutic potential of this novel compound.
NINGBO INNO PHARMCHEM CO.,LTD. is a trusted partner for companies looking to source high-quality Tegoprazan API. We ensure that our supply of the Tegoprazan pharmaceutical intermediate meets the rigorous standards required for pharmaceutical development. Our dedication supports ongoing Tegoprazan drug development, enabling the creation of advanced gastrointestinal treatments.
The accumulating Tegoprazan clinical trials results continue to validate its therapeutic benefits and favorable Tegoprazan safety profile. As a leading supplier, we are confident in Tegoprazan's contribution to improved patient outcomes in gastroenterology. Its role as a Tegoprazan H+/K+-ATPase inhibitor marks it as a key innovation in acid management.
NINGBO INNO PHARMCHEM CO.,LTD. is proud to be part of the pharmaceutical ecosystem that brings advanced treatments like Tegoprazan to market, driving progress in gastrointestinal healthcare.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
